Atlas Trials

Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients

Clinical trial NCT06682156 · RECRUITING

Trial details

NCT number
NCT06682156
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Study type
OBSERVATIONAL
Newly Diagnosed Multiple Myeloma
Start date
2024-09-10
Primary completion
2028-03-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.